ZYCLARA 3,75 %, crème — 28 sachet(s) polyester aluminium de 250 mg
Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France
-
CIP13
3400926879815 -
CIP7
2687981 -
CIS
69349666 -
Registration number
EU/1/12/783
What the source publishes
- Holder
- VIATRIS HEALTHCARE (IRLANDE)
- Active ingredients
- IMIQUIMOD
- Form
- crème
- Package
- 28 sachet(s) polyester aluminium de 250 mg
- Routes
- cutanée
- Administrative status
- authorised
- Supply regime
- liste I
- Marketing status
- Déclaration d'arrêt de commercialisation
- Authorised on
- 2012-08-23
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"cis": "69349666",
"cip7": "2687981",
"form": "crème",
"name": "ZYCLARA 3,75 %, crème — 28 sachet(s) polyester aluminium de 250 mg",
"cip13": "3400926879815",
"holder": "VIATRIS HEALTHCARE (IRLANDE)",
"routes": [
"cutanée"
],
"holders": [
"VIATRIS HEALTHCARE (IRLANDE)"
],
"currency": "EUR",
"marketed": false,
"bdmStatus": "Warning disponibilité",
"useDomain": "unknown",
"publicPrice": "52.90",
"authorisedOn": "2012-08-23",
"compositions": [
{
"name": "IMIQUIMOD",
"nature": "SA",
"strength": "3,75 mg",
"linkageNumber": "1",
"substanceCode": "93722",
"dosageReference": "100 mg de crème",
"pharmaceuticalElement": "crème"
}
],
"sourceStatus": "Présentation active",
"supplyRegime": "liste I",
"dispensingFee": "1.02",
"medicinePrice": "51.88",
"regionalRules": "not-collected",
"targetSpecies": [],
"specialityName": "ZYCLARA 3,75 %, crème",
"marketingStatus": "Déclaration d'arrêt de commercialisation",
"publicationDates": {
"CIS_bdpm": "2026-11-20",
"CIS_CIP_bdpm": "2026-11-20",
"CIS_CPD_bdpm": "2026-11-20",
"CIS_COMPO_bdpm": "2026-11-20"
},
"specialityListed": true,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "fr.ansm.bdpm"
},
"collectiveApproval": "oui",
"packageDescription": "28 sachet(s) polyester aluminium de 250 mg",
"patientEligibility": "not-assessed",
"reimbursementRates": [
"15 %"
],
"marketingDeclaredOn": "2026-09-30",
"targetSpeciesStatus": "not-reported",
"additionalMonitoring": false,
"administrativeStatus": "authorised",
"prescriptionCategory": "prescription-or-restricted",
"activeIngredientNames": [
"IMIQUIMOD"
],
"authorisationProcedure": "Procédure centralisée",
"prescriptionConditions": [
"liste I"
],
"reimbursementIndications": null,
"authorisationSourceStatus": "Autorisation active",
"europeanAuthorisationNumber": "EU/1/12/783",
"presentationAdministrativeStatus": "authorised"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=fr" \
--data-urlencode "sourceId=fr.ansm.bdpm" \
--data-urlencode "id=fr:ansm:packages:3400926879815"